Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)
China flag China · Delayed Price · Currency is CNY
2.630
-0.090 (-3.31%)
Nov 17, 2026, 3:00 PM CST

SHA:603363 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-728.0777.62579.35-3,651-1,038-1,520
Depreciation & Amortization
472.72472.83832.551,2351,2901,042
Other Amortization
27.5927.4796.2286.9759.4749.33
Loss (Gain) From Sale of Assets
-0.36-0.36-46.1638.28-2.562.38
Asset Writedown & Restructuring Costs
46.846.8174.46470.4351.2442.49
Loss (Gain) From Sale of Investments
32.432.4-1,4995.8314.4437.42
Provision & Write-off of Bad Debts
232355.6446.1624.8256.75
Other Operating Activities
1,071328.5188.72874.16791.48555.47
Change in Accounts Receivable
-435.76-435.76-3,695-301.33-47.36-146.7
Change in Inventory
-320.18-320.18455.312,073-1,223-1,290
Change in Accounts Payable
-94.15-94.152,734-15.19796.911,640
Change in Other Net Operating Assets
-0.38-0.380.7355.7451.8254.48
Operating Cash Flow
90.17152.94-116.78984.01663.64524.29
Operating Cash Flow Growth
---48.27%26.58%29.13%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-137.94-232.9-262.68-511.77-1,499-2,709
Sale of Property, Plant & Equipment
3.724.69164.8278.1813.8312.06
Cash Acquisitions
0.06-0.33-2.1-56.54-64.89-63.45
Divestitures
10.5764.2929.8246.99-0.195.6
Investment in Securities
0.06-4.0528.153.77-98.41-19.76
Other Investing Activities
10-2.762.94-82.71-54.61-32.2
Investing Cash Flow
-113.54-171.05-39.07-322.08-1,703-2,806

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-361.5957.627,5346,5685,995
Long-Term Debt Repaid
--795.58-1,403-8,066-6,440-4,427
Lease Payments
-106.34-106.34-71.68-272.24-455.97-434.81
Net Debt Issued (Repaid)
-365.84-434.08-445.76-532.77127.841,568
Issuance of Common Stock
261.91-1,709-1,6181,064
Repurchase of Common Stock
--7.1-35.64-8.44-61.82-3.11
Common Dividends Paid
-66.3-84.51-76.39-294.86-373.67-345.77
Other Financing Activities
77.18-41.06-15.22-294.26-89.69-83.36
Financing Cash Flow
-93.05-566.751,135-1,1301,2202,200

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.09-0.040-2.06-2.05-0.11
Net Cash Flow
-116.51-584.89979.64-470.46178.55-82.54

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-47.77-79.95-379.46472.23-835.31-2,184
Free Cash Flow Growth
------
Free Cash Flow Margin
-0.52%-0.94%-4.33%2.43%-3.86%-12.11%
Free Cash Flow Per Share
-0.02-0.03-0.440.55-1.08-3.36
Levered Free Cash Flow
331.22-865.58-2,317527.61-1,115-1,244
Unlevered Free Cash Flow
358.15-776.08-1,910871.35-799.01-982.65
Free Cash Flow After Leases
-154.11-186.29-451.15199.99-1,291-2,619

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
18.922.5619.4867.4421.1629.12
Cash Income Tax Paid
87.7678.8269.39108.2799.9385.41
Change in Working Capital
-855.32-855.32-498.221,878-526.51257.88